Evidence map›Paper›PMID 10908671›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors.

A Dace, L Zhao, K S Park, T Furuno, N Takamura, M Nakanishi, B L West, J A Hanover, S Cheng

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Thyroid hormone receptor phosphorylation regulates acute fasting-induced suppression of the hypothalamic-pituitary-thyroid axis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.Thyroid : official journal of the American Thyroid Association · 2020
    Article
  6. Article
  7. Review
  8. Methylcytosine dioxygenase TET3 interacts with thyroid hormone nuclear receptors and stabilizes their association to chromatin.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Thyroid hormone receptors and cancer.Biochimica et biophysica acta · 2013
    Review
  18. Article
  19. Article
  20. Back to your heart: ubiquitin proteasome system-regulated signal transduction.Journal of molecular and cellular cardiology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

A DaceLaboratory of Molecular Biology, National Cancer Institute, and Laboratory of Cellular Biochemistry and Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-4255, USA.
L Zhao
K S Park
T Furuno
N Takamura
M Nakanishi
B L West
J A Hanover
S Cheng
National Institutes of Health · USNagoya City University · JPNational Cancer Institute · USUniversity of California San Francisco Medical Center · US

Funding

ROLE OF THE NUCLEAR ENVELOPE IN INTRACELLULAR PROTEIN SORTINGZ01DK060000 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI HANOVER, JOHN A. · 1995 to 2006
–
6 · The paper itself

Abstract

The thyroid hormone 3,3',5-triiodo-l-thyronine (T3) is essential for growth, differentiation, and development. Its biological activities are mediated by T3 nuclear receptors (TRs). At present, how T3 regulates TR proteins and the resulting functional consequences are still unknown. Immunofluorescence analyses of endogenous TR in the growth hormone-producing GC cells showed that the T3-induced rapid degradation of TR was specifically blocked by lactacystin, a selective inhibitor of the ubiquitin-proteasome degradation pathway. Immunoblots demonstrated that the transfected TRbeta1 was ubiquitinated and that the ubiquitination was T3 independent. Studies with a series of truncated TRbeta1 showed that the hormone-binding domain was sufficient for the T3-induced rapid degradation of TRbeta1 by the proteasome degradation pathway. T3 also induced rapid degradation of TRbeta2 and TRalpha1. In contrast, the stability of the non-T3-binding TRalpha2 and naturally occurring TRbeta1 mutants that do not bind T3 was not affected by T3 treatment, indicating that hormone binding to receptor was essential for the degradation of the wild-type receptors. In the presence of proteasome protease inhibitors, the levels of both total and ubiquitinated TRbeta1 protein increased, yet T3-dependent transcriptional activation and the expression of the growth hormone gene were diminished, suggesting that proteasome-mediated degradation played a novel role in modulating transcriptional activation by TR. The present study reveals a role of T3 in modulating the functions of TR by regulating its receptor level via the ubiquitin-proteasome degradation pathway.

Indexed as

AnimalsCell LineCysteine EndopeptidasesDNA PrimersHumansHydrolysisMultienzyme ComplexesProteasome Endopeptidase ComplexProtein BindingReceptors, Thyroid HormoneThyroid HormonesCysteine EndopeptidasesDNA PrimersMultienzyme ComplexesProteasome Endopeptidase ComplexReceptors, Thyroid HormoneThyroid Hormones

Identifiers

PMID10908671
PMCPMC16808
OpenAlexW2082151361

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.